apoQlar Medical Awarded Two Year Grant to Supply HoloMedicine® Platform at the German Trias i Pujol Hospital
Badalona, Spain – June 21, 2024 – apoQlar medical Awarded Two-Year Grant – apoQlar medical, a pioneer in medical mixed reality (MR) and virtual reality (VR) solutions, is pleased to announce that it has been awarded a prestigious two-year grant by the Northern Metropolitan Territorial Management (NMTM) of the Catalan Health Institute (ICS). This significant grant will lead to the deployment of the HoloMedicine® Platform across multiple healthcare and educational units at the Germans Trias i Pujol Hospital, with the goal of empowering surgical planning and enhancing medical education.
Under this grant, apoQlar will supply a total of 30 advanced MR and VR devices. These state-of-the-art systems will be integrated with the HoloMedicine® Platform, a cutting-edge digital tool designed to transform preoperative planning and support medical learning experiences.
The integration of the platform aims to digitize 20% of surgical preoperative procedures. By leveraging the power of immersive technology, this initiative will allow surgeons to visualize and prepare for complex surgeries with greater precision. The system offers 3D visualization of patient-specific anatomy, enabling clinicians to plan strategies, reduce surgical risks, and improve postoperative results.
Beyond the clinical setting, the HoloMedicine® Platform will significantly contribute to healthcare education. It is expected to increase engagement and retention among students by providing interactive, immersive learning tools. Medical trainees and residents will have access to digital training modules, live-streamed procedures, and virtual educational assets such as detailed 3D anatomical models and instructional videos. These innovations aim to create a more impactful and modern learning experience.
“This grant represents a milestone in our mission to enhance healthcare through innovative technology,” said Sirko Pelzl, CEO of apoQlar. “We are excited to collaborate with ICS and leverage the capabilities of our HoloMedicine® Platform to improve both surgical outcomes and education. This project highlights our continued commitment to delivering impactful digital health solutions that benefit both patients and professionals.”
To support effective implementation, apoQlar will also provide comprehensive training and ongoing technical support to ensure a smooth transition and optimal use of the platform within all participating facilities under the NMTM.
apoQlar medical is at the forefront of innovation in mixed reality healthcare solutions, offering tools that transform patient care, education, and surgical planning. The HoloMedicine® Platform is used internationally to support better outcomes and more effective training through immersive MR and VR technologies.
For more information about apoQlar medical and its innovative solutions, visit http://www.apoQlar.com
Located in Badalona, Spain, the Germans Trias i Pujol University Hospital (HUGTiP) is a renowned tertiary care center known for clinical excellence, research, and teaching. It serves more than 800,000 residents across the Barcelonès Nord and Maresme areas, with 775 beds and 21 modern operating rooms. The hospital is part of the Can Ruti biomedical campus, a hub of innovation and collaboration.
The NMTM of the Catalan Health Institute (ICS) is responsible for healthcare services across Vallès Occidental, Vallès Oriental, Barcelonès Nord, and Maresme. Its network includes primary care units and HUGTiP, delivering high-quality medical services to over 1.4 million people.
Contact:
Sirko Pelzl, CEO
apoQlar
info@apoqlar.com
+49 40 241 927 79
